FRONTLINE HEALTHCARE PARTNERS
FRONTLINE HEALTHCARE PARTNERS is a Series C+ and buyout fund in the US investing in healthcare-tech, value-added-healthcare-services and multi-site-healthcare.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech, value-added-healthcare-services, multi-site-healthcare
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $168M
- Website
- frontlinehcp.com
Check size not disclosed
Thesis
Frontline Healthcare Partners (FHP) is a private equity firm founded in 2020 and based in Charleston, South Carolina. The firm specializes in investing in lower middle market, distributed healthcare businesses, with a focus on micro-cap companies in three core areas: Multi-Site Healthcare, Healthcare Technology, and Value-Added Healthcare Services. FHP's investment strategy involves partnering with founders and management teams, often through significant minority stake rollovers, and applying "White Coat" & "Blue Coat" principles to drive quality patient care and trust. Their inaugural fund, Frontline Healthcare Partners, L.P., closed at $125 million in December 2024, dedicated to control investments in micro-cap distributed healthcare businesses, typically with $1 to $5 million in EBITDA. The firm primarily invests in the United States and had approximately $168,147,525 in AUM as of March 30, 2026. They also leverage a network of Advisor Partners for specialized sector knowledge.
Common questions
Does FRONTLINE HEALTHCARE PARTNERS invest at the Series C+ stage?
Yes. FRONTLINE HEALTHCARE PARTNERS lists Series C+ and buyout among the stages it invests in.
Where does FRONTLINE HEALTHCARE PARTNERS invest?
FRONTLINE HEALTHCARE PARTNERS invests in the US.